undefined

Atul Rustgi

Partner at Accolade, with a background in working across both early-stage venture and late-stage growth equity strategies.

Top 3 podcasts with Atul Rustgi

Ranked by the Snipd community
undefined
10 snips
Feb 29, 2024 • 29min

E46: Atul Rustgi of Accolade on What is LP Value-Add and Can it Lead to Alpha?

Atul Rustgi discusses LP value-add in VC, biotech diversification, blockchain exposure, family office investments, and raising funds in a market downturn. They explore the complexities of VC relationships, navigating challenges in investing, and strategic asset allocation in blockchain. Also, reflections on reinvestment strategies, mentorship, and contrarian thinking in the investment landscape.
undefined
9 snips
Apr 28, 2023 • 1h 1min

LP Market Perspective - Nick & Beezer co-host Atul Rustgi, Accolade Partners

Origins is a podcast about the VC and LP ecosystem, co-hosted by Nick Chirls of Notation and Beezer Clarkson of Sapphire Partners. In this episode, we are joined by Atul Rustgi, managing partner of Accolade Partners, a top-performing venture capital, growth equity, and blockchain fund of funds. Prior to joining Accolade in 2007, Atul worked at McKinsey & Co., a leading strategy consulting firm, where he advised senior management on issues of strategy, organization, technology and operations. Before McKinsey, Atul worked at the Robin Hood Foundation, a venture philanthropy that funds and supports innovative poverty-fighting organizations in New York City. Atul holds an M.B.A. from Harvard Business School and a B.B.A. from the University of Michigan. Follow us: https://twitter.com/nchirls https://twitter.com/beezer232 https://twitter.com/AccoladePrtnrs
undefined
Jun 2, 2020 • 47min

Atul Rustgi, Accolade Partners

Atul Rustgi, Partner at Accolade, discusses evaluating VC managers, fund size, and COVID-19 impact. Talks about investing in early-stage venture and late-stage growth equity funds. Reflects on the evolution of the venture capital industry from 2007. Provides insights into current environment challenges and future outlook on software and healthcare investments.